← All trials
NCT04891172
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2021
- Primary completion
- Mar 1, 2022
- Completion date
- Aug 2, 2022
- First posted
- May 18, 2021
- Last posted
- Aug 24, 2021
- Enrollment
- 310
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Dow University of Health SciencesLead sponsor
- Government of PakistanCollaborator
- Dow University of Health SciencesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.